Eli Lilly & Co. closed $85.37 below its 52-week high ($972.53), which the company reached on August 22nd.

As summer heat turns to cool winds, hopes that this year would bring widespread industry relief have dissipated, with ...

The state of Texas has filed a lawsuit against drug companies that produce insulin and pharmacy benefit managers (PBM), claiming there is a conspiracy to k ...

Texas is suing insulin manufacturers and PBMs, including Eli Lilly and CVS Pharmacy, alleging a scheme to hike insulin prices ...

EXCLUSIVE: Filming has wrapped on Dragn, an under-the-radar horror-sci-fi film, starring James Paxton (Twisters), Carlos ...

The US Food and Drug Administration confirmed Thursday that Eli Lilly (LLY) has increased production of its blockbuster ...

Americans who turned to telehealth companies and compounding pharmacies for cheap versions of Eli Lilly & Co.’s weight-loss ...

Artificial intelligence is quickly becoming a valuable tool in the U.S. healthcare industry. Experts say a thoughtful ...

In a consultation the UK's drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include ...

NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...

Texas Attorney General Ken Paxton has filed a lawsuit against major insulin manufacturers and pharmacy benefit managers over an alleged conspiracy to increase i ...